MedPath

Efficacy of bevacizumab on brain radiation necrosis after irradiation for brain diseases.

Not Applicable
Conditions
brain radiation necrosis
Registration Number
JPRN-UMIN000024794
Lead Sponsor
Osaka Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

Patients had hemorrhagic diseases. Patients had allergy for bevacizumab. Patients were suspected tumor recurrence. Pregnant patients.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath